Eyenovia MiDD Usability Study

NCT03480906 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Pressure

Interventions

DRUG: Latanoprost
DRUG: Latanoprost

Sponsor

Eyenovia Inc.